ES515889A0 - Un procedimiento para la preparacion de compuestos. - Google Patents

Un procedimiento para la preparacion de compuestos.

Info

Publication number
ES515889A0
ES515889A0 ES515889A ES515889A ES515889A0 ES 515889 A0 ES515889 A0 ES 515889A0 ES 515889 A ES515889 A ES 515889A ES 515889 A ES515889 A ES 515889A ES 515889 A0 ES515889 A0 ES 515889A0
Authority
ES
Spain
Prior art keywords
compounds
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES515889A
Other languages
English (en)
Other versions
ES8308843A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Wuelfing GmbH and Co KG
Original Assignee
Beecham Wuelfing GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Wuelfing GmbH and Co KG filed Critical Beecham Wuelfing GmbH and Co KG
Publication of ES515889A0 publication Critical patent/ES515889A0/es
Publication of ES8308843A1 publication Critical patent/ES8308843A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
ES515889A 1981-09-24 1982-09-22 Un procedimiento para la preparacion de compuestos. Expired ES8308843A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8128857 1981-09-24

Publications (2)

Publication Number Publication Date
ES515889A0 true ES515889A0 (es) 1983-10-01
ES8308843A1 ES8308843A1 (es) 1983-10-01

Family

ID=10524707

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515889A Expired ES8308843A1 (es) 1981-09-24 1982-09-22 Un procedimiento para la preparacion de compuestos.

Country Status (8)

Country Link
US (1) US4485108A (es)
EP (1) EP0076072B1 (es)
JP (1) JPS5865267A (es)
AU (1) AU8862282A (es)
CA (1) CA1173443A (es)
DE (1) DE3276313D1 (es)
ES (1) ES8308843A1 (es)
ZA (1) ZA826953B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3363289D1 (de) * 1982-09-28 1986-06-05 Beecham Wuelfing Gmbh & Co Kg Sulfon amides
DE3721901A1 (de) * 1987-07-02 1989-01-12 Heidelberger Druckmasch Ag Schaltschrank
US5962490A (en) * 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en) * 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
IE903957A1 (en) * 1989-11-06 1991-05-08 Sanofi Sa Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present
US5378715A (en) * 1992-02-24 1995-01-03 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
US5514696A (en) * 1992-05-06 1996-05-07 Bristol-Myers Squibb Co. Phenyl sulfonamide endothelin antagonists
US5420123A (en) * 1992-12-21 1995-05-30 Bristol-Myers Squibb Company Dibenzodiazepine endothelin antagonists
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US5965732A (en) * 1993-08-30 1999-10-12 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
US5760038A (en) * 1995-02-06 1998-06-02 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
JPH09124620A (ja) 1995-10-11 1997-05-13 Bristol Myers Squibb Co 置換ビフェニルスルホンアミドエンドセリン拮抗剤
US5977117A (en) * 1996-01-05 1999-11-02 Texas Biotechnology Corporation Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
JP2000504677A (ja) * 1996-02-09 2000-04-18 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５ｈｔ７レセプター・アンタゴニスト用のスルホンアミド誘導体
US5856507A (en) * 1997-01-21 1999-01-05 Bristol-Myers Squibb Co. Methods for the preparation of biphenyl isoxazole sulfonamides
HUP0002351A3 (en) 1996-02-20 2001-10-29 Bristol Myers Squibb Co Methods for the preparation of biphenyl isoxazole sulfonamides, intermediates and process for preparing them
US5958905A (en) 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5939446A (en) * 1996-04-09 1999-08-17 Bristol-Myers Squibb Co. Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
GB9612884D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
US6025367A (en) * 1996-06-25 2000-02-15 Smithkline Beecham Plc Sulfonamide derivatives as 5HT7 receptor antagonists
DZ2376A1 (fr) * 1996-12-19 2002-12-28 Smithkline Beecham Plc Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
AU6187898A (en) * 1997-01-30 1998-08-25 Bristol-Myers Squibb Company Method for preventing or treating low renin hypertension by administering an endothelin antagonist
US5783705A (en) 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
NZ336898A (en) 1997-04-28 2001-10-26 Texas Biotechnology Corp Sulfonamides for treatment of endothelin-mediated disorders
KR20020004974A (ko) 1999-03-19 2002-01-16 스티븐 비. 데이비스 비페닐 이속사졸 술폰아미드의 제조방법
GB0130696D0 (en) * 2001-12-21 2002-02-06 Smithkline Beecham Plc Chemical Compounds
EP1676844A1 (en) 2004-12-28 2006-07-05 Laboratorios Del Dr. Esteve, S.A. 5-HT7 receptor antagonists
US7928121B2 (en) 2002-02-19 2011-04-19 Laboratorios Del Dr. Esteve, S.A. 5-HT7 receptor antagonists
US7553965B2 (en) 2002-11-07 2009-06-30 Laboratories Del Dr. Esteve, S.A. 5-HT7 receptor antagonists
EP1676840A1 (en) 2004-12-28 2006-07-05 Laboratorios Del Dr. Esteve, S.A. 5-HT7 Receptor antagonists
GB0314478D0 (en) * 2003-06-20 2003-07-23 Glaxo Group Ltd Compounds
GB0314479D0 (en) * 2003-06-20 2003-07-23 Glaxo Group Ltd Compounds
ES2257168B1 (es) 2004-08-18 2007-06-01 Laboratorios Del Dr Esteve, S.A. Ligandos del receptor 5-ht7.
US7211584B2 (en) 2004-08-18 2007-05-01 Laboratorios Del Dr. Esteve, S.A. 5-HT7 receptor ligands
US7211585B2 (en) 2004-08-18 2007-05-01 Laboratorios Del Dr. Esteve, S.A. 5-HT7 receptor antagonists
EP1630158A1 (en) 2004-08-18 2006-03-01 Laboratorios Del Dr. Esteve, S.A. 5-HT7 receptor antagonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2443246A1 (fr) * 1978-12-05 1980-07-04 Pharmindustrie Nouveaux medicaments a base de derives de la phenyl-1 (piperidyl-4)-3 propanone-1
NZ193654A (en) * 1979-05-16 1984-08-24 Wuelfing Johann A Naphthalene sulphonamido-alkyl-piperidines,pyrrolidines or piperazines and pharmaceutical compositions
EP0021570B1 (en) * 1979-05-23 1983-10-05 Imperial Chemical Industries Plc Process and apparatus for the treatment of waste water
DE3065026D1 (en) * 1979-05-23 1983-11-03 Beecham Wuelfing Gmbh & Co Kg Phenylsulphonamide derivatives, a process for their preparation and their use as medicines
FR2459235A1 (fr) * 1979-06-14 1981-01-09 Sanofi Sa Nouveaux derives de sulfonyl-aniline, leur procede de preparation et leur application therapeutique
DE3064946D1 (en) * 1979-09-11 1983-10-27 Commw Scient Ind Res Org A generator of high current pulses
DE2941597A1 (de) * 1979-10-13 1981-04-23 Basf Ag, 6700 Ludwigshafen Piperidinderivate von 4,5-dialkyl-3-hydroxy-pyrrol-2-carbonsaeureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
DE2950064A1 (de) * 1979-12-13 1981-06-19 Basf Ag, 6700 Ludwigshafen Piperidinderivate von 3-hydroxythiophen-2-carbonsaeure und -estern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen

Also Published As

Publication number Publication date
JPS5865267A (ja) 1983-04-18
ZA826953B (en) 1983-07-27
AU8862282A (en) 1983-03-31
ES8308843A1 (es) 1983-10-01
US4485108A (en) 1984-11-27
DE3276313D1 (en) 1987-06-19
EP0076072B1 (en) 1987-05-13
EP0076072A2 (en) 1983-04-06
EP0076072A3 (en) 1983-07-27
CA1173443A (en) 1984-08-28

Similar Documents

Publication Publication Date Title
ES515889A0 (es) Un procedimiento para la preparacion de compuestos.
ES513366A0 (es) Un procedimiento para la preparacion de nuevas n-aril-piperazin alcanamidas.
ES512882A0 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
ES510696A0 (es) Un procedimiento para la preparacion de nuevos tiojenos o furanos.
ES511123A0 (es) Un procedimiento para la preparacion de un dihidroxi-compuesto.
ES511124A0 (es) Un procedimiento para la preparacion de un dihidroxi-compuesto.
ES521318A0 (es) Un procedimiento para la preparacion de compuestos de bencimidazol.
ES511663A0 (es) Un procedimiento para la preparacion de un heteropoliacido.
ES514311A0 (es) Un procedimiento para la preparacion de benzofurasulfamatos.
ES514992A0 (es) Un procedimiento para la preparacion de un derivado carbostirilo.
ES509312A0 (es) Un procedimiento para la preparacion de 1-3-hidroxi-4-metoxibenzoil-3-hidroxi-2-pirrolidinona.
ES511665A0 (es) Un procedimiento para la preparacion de fenilaminoimidazolidinas.
ES509432A0 (es) Un procedimiento para la preparacion de arilaminas.
ES518289A0 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
ES502153A0 (es) Un procedimiento para la preparacion de compuestos n-acil-n- (cicloalquil) aminoacidos.
ES521152A0 (es) Un procedimiento para la preparacion de glutation.
ES515366A0 (es) Un procedimiento para la preparacion de un compuesto.
ES508775A0 (es) Un procedimiento para la preparacion de derivados de ciclo- hepteno.
ES509526A0 (es) Un procedimiento para la preparacion de dihigroimidazoles.
ES513737A0 (es) Un procedimiento para la preparacion de nuevas 1-benzoil sustituido-3-fenil sustituido-ureas.
ES515365A0 (es) Un procedimiento para la preparacion de un derivado de furanocremona.
ES512463A0 (es) Un procedimiento para la preparacion de un derivado de beta-lactama.
ES510881A0 (es) Un procedimiento para la preparacion de indenoimidazoles.
ES513034A0 (es) Un procedimiento para la preparacion de compuestos b -lactamicos.
ES511915A0 (es) Un procedimiento para la preparacion de 1-fenoxi-3-(tienil-t-butilamino)-2-propanoles.